Nairobi — UK drugmaker GlaxoSmithKline Limited (GSK) has rebranded to Haleon Kenya Limited, effective March 14, 2025. The rebrand comes after GSK transferred its consumer health business to Haleon to ...

With these trends in view, let’s look at the 7 most undervalued biotech stocks to invest in.

Amezosvatein has shown excellent immunogenicity and improved tolerability in Phase 2 study -- Medicxi leads round, joined by new investors ...

GlaxoSmithKline is investing in artificial ... clients in one quarter of the time normally needed. Exscientia and GSK aim to discover novel and selective small molecules for up to 10 disease ...

GlaxoSmithKline has agreed a $3.3 billion takeover ... that for years has been dominated by Pfizer's Prevnar franchise. GSK said it is paying $2.1 billion upfront for Cambridge, Massachusetts ...

Phil Stevens, from Hampshire, said he developed an addiction to gambling and spending after taking prescription medication ...

GlaxoSmithKline Limited (GSK) in Kenya has officially changed its legal entity name to Haleon Kenya Limited. Haleon ...

Manchester-based HIV charity George House Trust has won a GSK Impact Award – one of the nation’s top healthcare charity ...

Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.

Refractory chronic cough is a cough that persists for over 8 weeks and does not respond to treatment of any underlying cause. Recent randomised trials for refractory chronic cough have shown ...